100.82
price up icon0.61%   0.61
pre-market  プレマーケット:  101.50   0.68   +0.67%
loading

Rhythm Pharmaceuticals Inc (RYTM) 最新ニュース

pulisher
12:56 PM

Is a relief rally coming for Rhythm Pharmaceuticals Inc. holdersCPI Data & Low Volatility Stock Recommendations - newser.com

12:56 PM
pulisher
12:26 PM

Is Rhythm Pharmaceuticals Inc. trending in predictive chart modelsEarnings Beat & Long-Term Growth Stock Strategies - newser.com

12:26 PM
pulisher
Oct 12, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flowWeekly Trade Review & Fast Moving Stock Trade Plans - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Is Rhythm Pharmaceuticals Inc. stock dividend yield sustainableWeekly Market Summary & Weekly High Return Opportunities - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Long term hold vs stop loss in Rhythm Pharmaceuticals Inc.July 2025 Big Picture & Safe Entry Momentum Tips - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

What analysts say about Rhythm Pharmaceuticals Inc 1RV stockVolatility Index Analysis & Minimize Portfolio Damage with Warnings - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Using RSI to spot recovery in Rhythm Pharmaceuticals Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Should you hold or exit Rhythm Pharmaceuticals Inc. now2025 Top Gainers & Trade Opportunity Analysis - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What indicators show strength in Rhythm Pharmaceuticals Inc.Weekly Profit Recap & Capital Efficiency Focused Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Leo Wealth LLC Has $850,000 Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock a safe buy pre earningsCEO Change & Consistent Growth Equity Picks - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Rhythm Pharma Stock Gears Up For Its Next Move - inkl

Oct 09, 2025
pulisher
Oct 09, 2025

How to recover losses in Rhythm Pharmaceuticals Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Is Rhythm Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why Rhythm Pharmaceuticals Inc. (1RV) stock could be next leaderWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Is Rhythm Pharmaceuticals Inc a good long term investmentEconomic Indicators Overview & Low Risk Capital Growth Plans - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

What momentum shifts mean for Rhythm Pharmaceuticals Inc.July 2025 Reactions & Weekly Hot Stock Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Rhythm Pharmaceuticals Inc. rebound enough to break evenRecession Risk & Verified High Yield Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Using data tools to time your Rhythm Pharmaceuticals Inc. exitJuly 2025 Macro Moves & Intraday High Probability Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Rhythm Pharmaceuticals Inc. stock cheap at current valuationWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Institutional scanner results for Rhythm Pharmaceuticals Inc.Market Volume Report & Fast Exit/Entry Strategy Plans - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Should You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead? - Yahoo Finance

Oct 03, 2025
pulisher
Oct 02, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock a buy before earnings resultsJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com

Oct 02, 2025
pulisher
Sep 30, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com

Sep 30, 2025
pulisher
Sep 30, 2025

Bardet-Biedl Syndrome Pipeline 2025: Pioneering Clinical Developments by 8+ Global Leaders – DelveInsight | Featuring Rhythm Pharmaceuticals - Barchart.com

Sep 30, 2025
pulisher
Sep 29, 2025

Rhythm Pharmaceuticals stock price target raised by H.C. Wainwright to $110 - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

HC Wainwright & Co. Maintains Rhythm Pharmaceuticals (RYTM) Buy Recommendation - Nasdaq

Sep 29, 2025
pulisher
Sep 29, 2025

RYTM: HC Wainwright Raises Price Target, Maintains Buy Rating | - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring an 18.64% Potential Upside in the Rare Disease Biotech Space - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Play with 18.64% Upside Potential - DirectorsTalk Interviews

Sep 29, 2025
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
大文字化:     |  ボリューム (24 時間):